Cookson Peirce & Co. Inc. Has $758,000 Holdings in Sanofi (NASDAQ:SNY)

Cookson Peirce & Co. Inc. lessened its stake in Sanofi (NASDAQ:SNY - Free Report) by 96.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,235 shares of the company's stock after selling 484,123 shares during the quarter. Cookson Peirce & Co. Inc.'s holdings in Sanofi were worth $758,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. DGS Capital Management LLC raised its position in Sanofi by 3.5% during the fourth quarter. DGS Capital Management LLC now owns 10,194 shares of the company's stock worth $507,000 after acquiring an additional 345 shares in the last quarter. London & Capital Asset Management Ltd raised its position in Sanofi by 6.0% during the fourth quarter. London & Capital Asset Management Ltd now owns 212,533 shares of the company's stock worth $10,569,000 after acquiring an additional 12,089 shares in the last quarter. Simplicity Solutions LLC raised its position in Sanofi by 27.4% during the fourth quarter. Simplicity Solutions LLC now owns 96,102 shares of the company's stock worth $4,779,000 after acquiring an additional 20,662 shares in the last quarter. Koshinski Asset Management Inc. raised its position in Sanofi by 30.4% during the fourth quarter. Koshinski Asset Management Inc. now owns 4,941 shares of the company's stock worth $246,000 after acquiring an additional 1,153 shares in the last quarter. Finally, NewEdge Wealth LLC raised its position in Sanofi by 4.4% during the fourth quarter. NewEdge Wealth LLC now owns 22,319 shares of the company's stock worth $1,110,000 after acquiring an additional 949 shares in the last quarter. Institutional investors and hedge funds own 10.04% of the company's stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the stock. Morgan Stanley assumed coverage on shares of Sanofi in a research report on Tuesday, January 23rd. They set an "equal weight" rating and a $55.00 price target on the stock. StockNews.com lowered shares of Sanofi from a "strong-buy" rating to a "buy" rating in a research report on Tuesday, February 27th. Finally, TheStreet lowered shares of Sanofi from a "b" rating to a "c" rating in a research report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company's stock. According to data from MarketBeat, Sanofi presently has a consensus rating of "Hold" and an average target price of $55.00.

Sanofi Stock Performance

Sanofi stock traded up $0.31 during midday trading on Wednesday, hitting $46.11. The company's stock had a trading volume of 3,714,876 shares, compared to its average volume of 1,864,429. Sanofi has a 1-year low of $42.63 and a 1-year high of $57.82. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.27 and a quick ratio of 0.87. The company has a 50-day moving average price of $47.56 and a two-hundred day moving average price of $48.71. The company has a market cap of $116.64 billion, a price-to-earnings ratio of 19.57, a PEG ratio of 1.73 and a beta of 0.61.

Sanofi (NASDAQ:SNY - Get Free Report) last announced its quarterly earnings results on Thursday, February 1st. The company reported $0.89 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.94 by ($0.05). Sanofi had a net margin of 12.56% and a return on equity of 27.47%. The company had revenue of $11.76 billion for the quarter, compared to the consensus estimate of $13.02 billion. As a group, sell-side analysts predict that Sanofi will post 4.16 earnings per share for the current year.

Sanofi Increases Dividend

The company also recently declared an annual dividend, which will be paid on Thursday, June 6th. Stockholders of record on Friday, May 10th will be given a $1.478 dividend. The ex-dividend date is Thursday, May 9th. This represents a dividend yield of 2.98%. This is an increase from Sanofi's previous annual dividend of $1.38. Sanofi's payout ratio is 62.29%.

Sanofi Company Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.